In addition to GLP-1/GIP/GCG receptors tri-agonists, there are also triagonists targeting Xenopus GLP-1/GCG/Cholecystokinin-2 (CCK2) receptors [107], GLP-1/GCG/ neuropeptide Y 2 receptors [108], and GLP-1R, neuropeptide Y1, and neuropeptide Y2 receptors [109]
[8] Hydration status: Gastrointestinal side effects such as vomiting and diarrhoea increase the risk of dehydration, which is a well-recognised contributor to fatigue
This overview covers the primary Russian and international research literature
However, its not something you can just take and forget
At MedBridge, our team tailors GLP-1 treatments to each patients unique needs, helping them experience early reductions in appetite and improved control over food intake
Semaglutide is often covered more easily by insurance